83 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34951582 | 5-Fluorouracil-Impregnated PLGA Coated Gold Nanoparticles for Augmented Delivery to Lung Cancer: In Vitro Investigations. | 2022 | 1 |
2 | 35241559 | Retrospective Study of Cisplatin/Carboplatin, 5-Fluorouracil Plus Cetuximab (EXTREME) for Advanced-stage Salivary Gland Cancer. | 2022 Mar-Apr | 2 |
3 | 35326562 | Impact of Delaying the Addition of Anti-EGFR in First Line of RAS Wild-Type Metastatic Colorectal Cancer: A Propensity-Weighted Pooled Data Analysis. | 2022 Mar 10 | 1 |
4 | 33349222 | Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer. | 2021 | 2 |
5 | 33538278 | Cetuximab functionalization strategy for combining active targeting and antimigration capacities of a hybrid composite nanoplatform applied to deliver 5-fluorouracil: toward colorectal cancer treatment. | 2021 Mar 21 | 1 |
6 | 33951601 | DNA damage response- and JAK-dependent regulation of PD-L1 expression in head and neck squamous cell carcinoma (HNSCC) cells exposed to 5-fluorouracil (5-FU). | 2021 Aug | 2 |
7 | 34026617 | Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers. | 2021 | 1 |
8 | 34097885 | Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma Models. | 2021 Sep | 4 |
9 | 34589581 | Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis. | 2021 Dec 17 | 7 |
10 | 31837576 | Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher. | 2020 Feb | 1 |
11 | 31840981 | Enzymes Photo-Cross-Linked to Live Cell Receptors Retain Activity and EGFR Inhibition after Both Internalization and Recycling. | 2020 Jan 15 | 1 |
12 | 31896739 | Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer. | 2020 Jan 2 | 4 |
13 | 31947551 | Anti-EGFR-Coated Gold Nanoparticles In Vitro Carry 5-Fluorouracil to Colorectal Cancer Cells. | 2020 Jan 14 | 4 |
14 | 31959339 | Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER). | 2020 Feb | 1 |
15 | 32043796 | Withholding the Introduction of Anti-Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild-Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study). | 2020 Feb | 1 |
16 | 32742490 | Combinational inhibition of EGFR and YAP reverses 5-Fu resistance in colorectal cancer. | 2020 | 1 |
17 | 33033330 | Targeted delivery of 5-fluorouracil-1-acetic acid (5-FA) to cancer cells overexpressing epithelial growth factor receptor (EGFR) using virus-like nanoparticles. | 2020 Oct 8 | 1 |
18 | 33408498 | The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients. | 2020 | 2 |
19 | 30662270 | Complete response with fluorouracil and irinotecan with a BRAFV600E and EGFR inhibitor in BRAF-mutated metastatic colorectal cancer: a case report. | 2019 | 2 |
20 | 30825616 | Induction of autophagy enhances apoptotic cell death via epidermal growth factor receptor inhibition by canertinib in cervical cancer cells. | 2019 May | 4 |
21 | 31189612 | Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin Uptake. | 2019 Aug | 2 |
22 | 31346466 | A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab. | 2019 | 2 |
23 | 31488078 | Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer. | 2019 Sep 5 | 1 |
24 | 31696188 | Bypassing pro-survival and resistance mechanisms of autophagy in EGFR-positive lung cancer cells by targeted delivery of 5FU using theranostic Ag2S quantum dots. | 2019 Dec 14 | 3 |
25 | 29086459 | Epidermal Growth Factor and Granulocyte Colony Stimulating Factor Signaling Are Synergistic for Hematopoietic Regeneration. | 2018 Feb | 2 |
26 | 29480364 | Combination of S-1 and gefitinib increases the sensitivity to radiotherapy in lung cancer cells. | 2018 Apr | 1 |
27 | 29864476 | Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection. | 2018 Aug 10 | 3 |
28 | 30056083 | Manuka honey synergistically enhances the chemopreventive effect of 5-fluorouracil on human colon cancer cells by inducing oxidative stress and apoptosis, altering metabolic phenotypes and suppressing metastasis ability. | 2018 Oct | 1 |
29 | 27878272 | miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer. | 2017 Jan | 2 |
30 | 26505786 | Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways. | 2016 Jan 11 | 1 |
31 | 27091477 | Epidermal growth factor receptor inhibitor with fluorouracil, leucovorin, and irinotecan as an alternative treatment for advanced upper tract urothelial carcinoma: a case report. | 2016 Apr 18 | 1 |
32 | 27268079 | Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer. | 2016 Jun 6 | 4 |
33 | 27340349 | Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancer. | 2016 Jun 21 | 2 |
34 | 27602148 | Enhancing chemosensitivity in oral squamous cell carcinoma by lentivirus vector-mediated RNA interference targeting EGFR and MRP2. | 2016 Sep | 2 |
35 | 27610130 | Prognostic Impact of mRNA Expression Levels of HER1-4 (ERBB1-4) in Patients with Locally Advanced Rectal Cancer. | 2016 | 1 |
36 | 27833077 | Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy. | 2016 Dec 6 | 2 |
37 | 25573239 | Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase‑inhibitory fluoropyrimidine in EGFR‑mutated lung adenocarcinoma: retrospective and in vitro studies. | 2015 Mar | 2 |
38 | 25750344 | Associations between driver gene mutations and cytotoxic chemosensitivity in patients with non-small cell lung cancer. | 2015 Mar | 3 |
39 | 26088456 | First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis. | 2015 Oct | 1 |
40 | 26275292 | Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature. | 2015 | 1 |
41 | 24405586 | High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil. | 2014 Mar | 5 |
42 | 24591842 | Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids. | 2014 | 1 |
43 | 22052826 | Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck. | 2013 Mar | 1 |
44 | 23708506 | Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models. | 2013 Aug | 1 |
45 | 23755922 | Epidermal growth factor receptor expression as prognostic marker in patients with anal carcinoma treated with concurrent chemoradiation therapy. | 2013 Aug 1 | 2 |
46 | 23800895 | Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy. | 2013 Dec | 5 |
47 | 23822592 | Which is false: oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody. | 2013 Oct | 4 |
48 | 24221219 | [Therapy of recurrent and metastatic squamous cell carcinoma of the head and neck : highlights of the ASCO Meeting 2013]. | 2013 Nov | 1 |
49 | 24351824 | Cbl-b enhances sensitivity to 5-fluorouracil via EGFR- and mitochondria-mediated pathways in gastric cancer cells. | 2013 Dec 16 | 2 |
50 | 21947696 | Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin. | 2012 Mar | 1 |